| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |